Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Peptides & Elephants is a specialized biotechnology company based in Germany that focuses on high-throughput peptide synthesis and the development of peptide-based research tools. The company leverages its proprietary laser-printing technology to manufacture high-density peptide microarrays and large-scale peptide libraries with high precision. Their service portfolio includes custom peptide synthesis, epitope mapping, and the production of peptide pools for T-cell assays and vaccine research. By providing rapid and cost-effective access to complex peptide sequences, Peptides & Elephants enables advancements in drug discovery, diagnostics, and personalized medicine. The company's unique approach allows for the simultaneous synthesis of thousands of peptides, significantly accelerating the screening process for researchers in immunology and oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Peptides & Elephants.